Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0376358 (
prostate cancer
)
59,338
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Human tissue kallikrein 14 (
KLK14
) is a novel extracellular serine protease. Clinical data link
KLK14
expression to several diseases, primarily cancer; however, little is known of its (patho)-physiological role. To functionally characterize
KLK14
, we expressed and purified recombinant
KLK14
in mature and proenzyme forms and determined its expression pattern, specificity, regulation, and in vitro substrates. By using our novel immunoassay, the normal and/or diseased skin, breast, prostate, and ovary contained the highest concentration of
KLK14
. Serum
KLK14
levels were significantly elevated in
prostate cancer
patients compared with healthy males.
KLK14
displayed trypsin-like specificity with high selectivity for P1-Arg over Lys.
KLK14
activity could be regulated as follows: 1) by autolytic cleavage leading to enzymatic inactivation; 2) by the inhibitory serpins alpha1-antitrypsin, alpha2-antiplasmin, antithrombin III, and alpha1-antichymotrypsin with second order rate constants (k(+2)/Ki) of 49.8, 23.8, 1.48, and 0.224 microM(-1) min(-1), respectively, as well as plasminogen activator inhibitor-1; and 3) by citrate and zinc ions, which exerted stimulatory and inhibitory effects on
KLK14
activity, respectively. We also expanded the in vitro target repertoire of
KLK14
to include collagens I-IV, fibronectin, laminin, kininogen, fibrinogen, plasminogen, vitronectin, and insulin-like growth factor-binding proteins 2 and 3. Our results indicate that
KLK14
may be implicated in several facets of tumor progression, including growth, invasion, and angiogenesis, as well as in arthritic disease via deterioration of cartilage. These findings may have clinical implications for the management of cancer and other disorders in which
KLK14
activity is elevated.
...
PMID:Expression and functional characterization of the cancer-related serine protease, human tissue kallikrein 14. 1711 Mar 83